Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Non-Current Assets: 2009-2025

Historic Non-Current Assets for BIO-TECHNE (TECH) over the last 17 years, with Jun 2025 value amounting to $245.7 million.

  • BIO-TECHNE's Non-Current Assets fell 8.18% to $1.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 billion, marking a year-over-year decrease of 8.18%. This contributed to the annual value of $245.7 million for FY2025, which is 2.16% down from last year.
  • Latest data reveals that BIO-TECHNE reported Non-Current Assets of $245.7 million as of FY2025, which was down 2.16% from $251.2 million recorded in FY2024.
  • BIO-TECHNE's 5-year Non-Current Assets high stood at $251.2 million for FY2024, and its period low was $207.9 million during FY2021.
  • Its 3-year average for Non-Current Assets is $241.0 million, with a median of $245.7 million in 2025.
  • Per our database at Business Quant, BIO-TECHNE's Non-Current Assets rose by 17.58% in 2021 and then fell by 2.16% in 2025.
  • BIO-TECHNE's Non-Current Assets (Yearly) stood at $207.9 million in 2021, then climbed by 7.38% to $223.2 million in 2022, then grew by 1.33% to $226.2 million in 2023, then climbed by 11.03% to $251.2 million in 2024, then declined by 2.16% to $245.7 million in 2025.